The legal and common uses of “interchangeability” continue to be conflated.
Gillian Woollett, MA, DPhil
Advertisement
Articles by Gillian Woollett, MA, DPhil
The "interchangeable" designation has created confusion around the difference between biosimilars designated as interchangeable and those that are not.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
Oxaliplatin as Part of Sequential Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
5
